(13-143) Evaluation of Indication, Dosing and Compliance with Restriction Criteria of Isavuconazonium Sulfate

Wednesday, December 7, 2022

3:15 PM – 4:15 PM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Infectious Diseases/HIV

Co-Author(s): Vivek Kataria

Primary Author(s)

Eleni A. Gaspar, PharmD
Primary Author
Baylor University Medical Center, South Carolina